X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (397) 397
Book Review (92) 92
Publication (33) 33
Book Chapter (9) 9
Book / eBook (8) 8
Conference Proceeding (5) 5
Dissertation (2) 2
Government Document (2) 2
Web Resource (1) 1
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
index medicus (255) 255
humans (201) 201
multi-drug resistance (197) 197
drug resistance (142) 142
pharmacology & pharmacy (114) 114
animals (93) 93
cancer (82) 82
nanoparticles (69) 69
female (67) 67
drug delivery systems (64) 64
drugs (61) 61
p-glycoprotein (61) 61
chemotherapy (58) 58
tuberculosis (58) 58
in-vitro (57) 57
analysis (56) 56
cell line, tumor (50) 50
drug resistance in microorganisms (50) 50
infectious diseases (49) 49
medicine (49) 49
male (48) 48
drug therapy (47) 47
doxorubicin (40) 40
health aspects (40) 40
mice (38) 38
multidrug-resistance (38) 38
drug resistance, neoplasm (37) 37
multi-drug-resistant tuberculosis (37) 37
multidrug resistance (37) 37
drug delivery (35) 35
drug-delivery (35) 35
research article (35) 35
care and treatment (34) 34
chemistry, multidisciplinary (34) 34
drug resistance, multiple (34) 34
biochemistry & molecular biology (33) 33
antibiotics (31) 31
bacterial diseases (31) 31
cells (30) 30
delivery (30) 30
paclitaxel (30) 30
patients (30) 30
vehicles (30) 30
neoplasms - drug therapy (29) 29
science (29) 29
therapy (29) 29
apoptosis (28) 28
bacteria (28) 28
nanoparticles - chemistry (28) 28
research (28) 28
materials science, biomaterials (27) 27
multi drug resistance (27) 27
multidisciplinary sciences (27) 27
oncology (27) 27
pharmacy (27) 27
adult (26) 26
nanoscience & nanotechnology (26) 26
proteins (26) 26
public health (26) 26
tuberculosis, multidrug-resistant - drug therapy (26) 26
antitubercular agents - therapeutic use (25) 25
breast cancer (25) 25
microbiology (25) 25
antineoplastic agents - pharmacology (24) 24
article (24) 24
biophysics (23) 23
medical research (23) 23
nanotechnology (23) 23
cytotoxicity (22) 22
doxorubicin - pharmacology (22) 22
drug resistance, multiple - drug effects (22) 22
micelles (22) 22
tropical diseases (22) 22
breast-cancer (21) 21
drug-resistance (21) 21
medicine and health sciences (21) 21
tumors (21) 21
hiv (20) 20
middle aged (20) 20
multidrug resistant organisms (20) 20
chemistry, medicinal (19) 19
drug carriers - chemistry (19) 19
infections (19) 19
studies (19) 19
co-delivery (18) 18
drug resistance, multiple, bacterial (18) 18
drug resistance, neoplasm - drug effects (18) 18
epidemiology (18) 18
liposomes (18) 18
particle size (18) 18
release (18) 18
anthracyclines (17) 17
antineoplastic agents - administration & dosage (17) 17
antineoplastic agents - therapeutic use (17) 17
cell survival - drug effects (17) 17
multi-drug resistant (17) 17
resistance (17) 17
review (17) 17
adolescent (16) 16
anti-bacterial agents - pharmacology (16) 16
more...
Library Location Library Location
Language Language
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Journal Article
International Journal of Pharmaceutics, ISSN 0378-5173, 04/2014, Volume 464, Issue 1-2, pp. 178 - 184
Journal Article
Journal of Nanomedicine and Nanotechnology, ISSN 2157-7439, 2013, Volume 4, Issue 2, pp. 6 - 1
Paclitaxel is one of the most effective chemotherapeutic drugs ever developed and is active against a broad range of cancers, such as lung, ovarian, and breast... 
Nanoparticles | Multi-drug resistance | Drug-polymer conjugates | Poly(lactic-co-glycolic acid) | Solid lipid nanoparticles | Nanocapsules | Drugs | Nanocomposites | Taxol | Ethyl alcohol | Nanomaterials | Nanostructure | Cancer
Journal Article
Nano Today, ISSN 1748-0132, 08/2012, Volume 7, Issue 4, pp. 367 - 379
Journal Article
Journal Article
Journal Article
International Journal of Nanomedicine, ISSN 1176-9114, 01/2017, Volume 12, pp. 671 - 681
Chemotherapy has been widely used in breast cancer patients to reduce tumor size. However, most anticancer agents cannot differentiate between cancerous and... 
Xenograft mouse tumor model | Targeted drug delivery | Combination therapy | Multidrug resistance | Immunoliposome | multidrug resistance | PEGYLATED LIPOSOMAL DOXORUBICIN | ANGIOGENESIS | BEVACIZUMAB | targeted drug delivery | NANOSCIENCE & NANOTECHNOLOGY | MONOCLONAL-ANTIBODY | COMBRETASTATIN | DRUG-RESISTANCE | xenograft mouse tumor model | PHASE-II TRIAL | THERAPY | GROWTH | combination therapy | PHARMACOLOGY & PHARMACY | immunoliposome | PLUS | Doxorubicin - therapeutic use | Bevacizumab - pharmacology | Tissue Distribution - drug effects | Bevacizumab - therapeutic use | Drug Resistance, Multiple - drug effects | Humans | Fluorescence | Antineoplastic Agents - therapeutic use | Breast Neoplasms - drug therapy | Particle Size | Animals | Tumor Burden - drug effects | Breast Neoplasms - pathology | Cell Line, Tumor | Drug Liberation | Female | Antineoplastic Agents - pharmacology | Cell Proliferation - drug effects | Mice, Inbred BALB C | Liposomes | Drug Delivery Systems - methods | Doxorubicin - pharmacology | Drug Resistance, Neoplasm - drug effects | Drugs | Drug delivery systems | Usage | Breast cancer | Dosage and administration | Research | Drug therapy | Drug resistance | Doxorubicin | Vehicles | Cell culture | Metastasis | FDA approval | Cancer therapies | Ovarian cancer | Survival analysis | Angiogenesis | Chemotherapy | Medical prognosis | Ligands | Growth factors | Tumors | Index Medicus | multi-drug resistance
Journal Article
Journal of Controlled Release, ISSN 0168-3659, 05/2016, Volume 229, pp. 183 - 191
Functional nanocarriers capable of transporting high drug contents without premature leakage and to controllably deliver several drugs are needed for better... 
Mesoporous silica nanoparticles | Multi-drug delivery | Bovine serum albumin | Gold nanoclusters | Cancer | BRIDGED SILSESQUIOXANE NANOPARTICLES | VITRO | PEGYLATED LIPOSOMAL DOXORUBICIN | COMBINATION | CHEMISTRY, MULTIDISCIPLINARY | GEMCITABINE | BREAST-CANCER | NANOCLUSTERS | RESPONSIVE CONTROLLED-RELEASE | FLUORESCENT-PROBES | PHARMACOLOGY & PHARMACY | ORGANOSILICA NANOPARTICLES | Silicon Dioxide - administration & dosage | Deoxycytidine - chemistry | Gold - administration & dosage | Nanocomposites - chemistry | Nanoparticles - chemistry | Serum Albumin, Bovine - administration & dosage | Humans | Drug Carriers - administration & dosage | Doxorubicin - chemistry | Antineoplastic Agents - administration & dosage | Drug Carriers - chemistry | Serum Albumin, Bovine - chemistry | Doxorubicin - administration & dosage | Gold - chemistry | A549 Cells | Cell Line | Deoxycytidine - administration & dosage | Silicon Dioxide - chemistry | Antineoplastic Agents - chemistry | Neoplasms - diagnostic imaging | Neoplasms - drug therapy | Drug Liberation | Nanoparticles - administration & dosage | Porosity | Deoxycytidine - analogs & derivatives | Nanocomposites - administration & dosage | Nanoparticles | Drugs | Albumin | Precious metal products | Silica | Tumors | Drug delivery systems | Anthracyclines | Pharmaceutical industry | Vehicles | Index Medicus
Journal Article
Journal Article
Journal Article